{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:21:18Z","timestamp":1789168878295,"version":"build-2803163510"},"reference-count":169,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI183687"],"award-info":[{"award-number":["R01AI183687"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI176245"],"award-info":[{"award-number":["AI176245"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.dmd.2025.100188","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:06:41Z","timestamp":1761181601000},"page":"100188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Novel emerging cell and organoid systems for the study of drug metabolism and toxicity in humans"],"prefix":"10.1016","volume":"53","author":[{"given":"Emily G.","family":"Gracey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0794-2263","authenticated-orcid":false,"given":"Jed N.","family":"Lampe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.dmd.2025.100188_bib1","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"issue":"12","key":"10.1016\/j.dmd.2025.100188_bib3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nrd.2016.184","article-title":"Phase II and phase III failures: 2013\u20132015","volume":"15","author":"Harrison","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.dmd.2025.100188_bib4","article-title":"Fail Early, Fail fast\u2014a phenotypic rescue approach","author":"Zuurmond","year":"2025","journal-title":"Drug Discovery World"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01480549509017855","article-title":"The application of in vitro models of drug metabolism and toxicity in drug discovery and drug development","volume":"18","author":"Ball","year":"1995","journal-title":"Drug Chem Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.01.001","article-title":"A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity","volume":"134","author":"Astashkina","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100188_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fphar.2018.00006","article-title":"Three-dimensional in vitro cell culture models in drug discovery and drug repositioning","volume":"9","author":"Langhans","year":"2018","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3390\/bioengineering7030115","article-title":"Innovative human three-dimensional tissue-engineered models as an alternative to animal testing","volume":"7","author":"B\u00e9dard","year":"2020","journal-title":"Bioengineering (Basel)"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00204-023-03648-4","article-title":"Impact of plastic-related compounds on the gene expression signature of HepG2 cells transfected with CYP3A4","volume":"98","author":"Rosellini","year":"2024","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12929-024-00994-y","article-title":"Scaffold-based 3D cell culture models in cancer research","volume":"31","author":"Abuwatfa","year":"2024","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.dmd.2025.100188_bib11","first-page":"475","article-title":"Biofabrication methods for reconstructing extracellular matrix mimetics","volume":"31","author":"Aazmi","year":"2024","journal-title":"Bioact Mater"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41231-019-0050-7","article-title":"Lost in translation: the valley of death across preclinical and clinical divide \u2013 identification of problems and overcoming obstacles","volume":"4","author":"Seyhan","year":"2019","journal-title":"Transl Med Commun"},{"issue":"8","key":"10.1016\/j.dmd.2025.100188_bib13","first-page":"1","article-title":"Human disease models in drug development","volume":"1","author":"Loewa","year":"2023","journal-title":"Nat Rev Bioeng"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100050","article-title":"Leveraging 3D cell culture and AI technologies for next-generation drug discovery","volume":"1","author":"Dave","year":"2025","journal-title":"Cell Biomater"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/cimb47010007","article-title":"Advanced in vitro models for preclinical drug safety: recent progress and prospects","volume":"47","author":"Nair","year":"2024","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat Rev Methods Primers"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib17","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1039\/D4LC01011F","article-title":"Advances of dual-organ and multi-organ systems for gut, lung, skin and liver models in absorption and metabolism studies","volume":"25","author":"Brandauer","year":"2025","journal-title":"Lab Chip"},{"issue":"9","key":"10.1016\/j.dmd.2025.100188_bib18","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.xphs.2024.06.016","article-title":"Applications of organoids in advancing drug discovery and development","volume":"113","author":"Gopallawa","year":"2024","journal-title":"J Pharm Sci"},{"issue":"s1","key":"10.1016\/j.dmd.2025.100188_bib19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0007114517002227","article-title":"The 3Rs in research: a contemporary approach to replacement, reduction and refinement","volume":"120","author":"MacArthur Clark","year":"2018","journal-title":"Br J Nutr"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/d41573-025-00087-x","article-title":"Is the FDA\u2019s plan to phase out animal toxicity testing realistic?","volume":"24","author":"Mullard","year":"2025","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1016\/j.dmd.2025.100188_bib21","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.drudis.2016.07.003","article-title":"Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling","volume":"21","author":"Skardal","year":"2016","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.dmd.2025.100188_bib22","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/1389200033489424","article-title":"Human hepatocytes as a tool for studying toxicity and drug metabolism","volume":"4","author":"G\u00f3mez-Lech\u00f3n","year":"2003","journal-title":"Curr Drug Metab"},{"issue":"7","key":"10.1016\/j.dmd.2025.100188_bib23","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00204-021-03050-y","article-title":"Assessment of long-term functional maintenance of primary human hepatocytes to predict drug-induced hepatoxicity in vitro","volume":"95","author":"Chen","year":"2021","journal-title":"Arch Toxicol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100188_bib24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.apsb.2018.04.003","article-title":"Drug metabolism in drug discovery and development","volume":"8","author":"Zhang","year":"2018","journal-title":"Acta Pharm Sin B"},{"issue":"19","key":"10.1016\/j.dmd.2025.100188_bib25","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1021\/acs.jmedchem.6b00472","article-title":"The \u201ccyclopropyl fragment\u201d is a versatile player that frequently appears in preclinical\/clinical drug molecules","volume":"59","author":"Talele","year":"2016","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/ph17030281","article-title":"The role of small molecules containing fluorine atoms in medicine and imaging applications","volume":"17","author":"Henary","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"19","key":"10.1016\/j.dmd.2025.100188_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911428","article-title":"In vitro models for studying chronic drug-induced liver injury","volume":"23","author":"Donato","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.dmd.2025.100188_bib28","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1016\/j.celrep.2019.10.128","article-title":"Maintenance of primary hepatocyte functions in vitro by inhibiting mechanical tension-induced YAP activation","volume":"29","author":"Sun","year":"2019","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.dmd.2025.100188_bib29","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","article-title":"Hep G2 is a hepatoblastoma-derived cell line","volume":"40","author":"L\u00f3pez-Terrada","year":"2009","journal-title":"Hum Pathol"},{"issue":"23","key":"10.1016\/j.dmd.2025.100188_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313135","article-title":"The curious case of the HepG2 cell line: 40 years of expertise","volume":"22","author":"Arzumanian","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4455","key":"10.1016\/j.dmd.2025.100188_bib31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6248960","article-title":"Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen","volume":"209","author":"Knowles","year":"1980","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbalip.2015.10.008","article-title":"Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism","volume":"1861","author":"Pramfalk","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib33","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/dmd.110.035873","article-title":"Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes","volume":"39","author":"Guo","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"8","key":"10.1016\/j.dmd.2025.100188_bib34","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.tiv.2007.05.014","article-title":"Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells","volume":"21","author":"Westerink","year":"2007","journal-title":"Toxicol In Vitro"},{"issue":"5","key":"10.1016\/j.dmd.2025.100188_bib35","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1248\/bpb.b17-00913","article-title":"Comparison of drug metabolism and its related hepatotoxic effects in HepaRG, cryopreserved human hepatocytes, and HepG2 cell cultures","volume":"41","author":"Yokoyama","year":"2018","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/03602532.2022.2039688","article-title":"Through a glass, darkly? HepaRG and HepG2 cells as models of human phase I drug metabolism","volume":"54","author":"Stanley","year":"2022","journal-title":"Drug Metab Rev"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib37","first-page":"68","article-title":"Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity","volume":"39","author":"Chen","year":"2021","journal-title":"J Environ Sci Health C Toxicol Carcinog"},{"key":"10.1016\/j.dmd.2025.100188_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tox.2018.11.008","article-title":"Metabolic activity testing can underestimate acute drug cytotoxicity as revealed by HepG2 cell clones overexpressing cytochrome P450 2C19 and 3A4","volume":"412","author":"Steinbrecht","year":"2019","journal-title":"Toxicology"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib39","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00204-013-1012-x","article-title":"HepG2 cells simultaneously expressing five P450 enzymes for the screening of hepatotoxicity: identification of bioactivable drugs and the potential mechanism of toxicity involved","volume":"87","author":"Tolosa","year":"2013","journal-title":"Arch Toxicol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229106","article-title":"A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction","volume":"15","author":"Bulutoglu","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.dmd.2025.100188_bib41","first-page":"3858","article-title":"Growth of human hepatoma cells lines with differentiated functions in chemically defined medium","volume":"42","author":"Nakabayashi","year":"1982","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13577-018-0212-3","article-title":"HuH-7 reference genome profile: complex karyotype composed of massive loss of heterozygosity","volume":"31","author":"Kasai","year":"2018","journal-title":"Hum Cell"},{"key":"10.1016\/j.dmd.2025.100188_bib43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejps.2019.01.022","article-title":"Protein expression and function of organic anion transporters in short-term and long-term cultures of Huh7 human hepatoma cells","volume":"130","author":"Malinen","year":"2019","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pharmaceutics9010003","article-title":"Drug transporter expression and activity in human hepatoma HuH-7 cells","volume":"9","author":"Jouan","year":"2016","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1124\/mol.112.082305","article-title":"Induced CYP3A4 expression in confluent Huh7 hepatoma cells as a result of decreased cell proliferation and subsequent pregnane X receptor activation","volume":"83","author":"Sivertsson","year":"2013","journal-title":"Mol Pharmacol"},{"issue":"8","key":"10.1016\/j.dmd.2025.100188_bib46","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1124\/dmd.117.076307","article-title":"CRISPR\/Cas9 genetic modification of CYP3A5 \u22173 in HuH-7 human hepatocyte cell line leads to cell lines with increased midazolam and tacrolimus metabolism","volume":"45","author":"Dorr","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100188_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/srep17455","article-title":"Acetaminophen cytotoxicity is ameliorated in a human liver organotypic co-culture model","volume":"5","author":"Nelson","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18174-z","article-title":"A novel differentiated HuH-7 cell model to examine bile acid metabolism, transport and cholestatic hepatotoxicity","volume":"12","author":"Saran","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13046-018-0872-6","article-title":"Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours","volume":"37","author":"Nwosu","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.dmd.2025.100188_bib50","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2004.01.002","article-title":"Origin and characterization of a human bipotent liver progenitor cell line","volume":"126","author":"Parent","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins","volume":"28","author":"Gerets","year":"2012","journal-title":"Cell Biol Toxicol"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib52","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1124\/dmd.116.074377","article-title":"Human enterocytes as an in vitro model for the evaluation of intestinal drug metabolism: characterization of drug-metabolizing enzyme activities of cryopreserved human enterocytes from twenty-four donors","volume":"45","author":"Ho","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100188_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107962","article-title":"Gutsy science: in vitro systems of the human intestine to model oral drug disposition","volume":"230","author":"Arian","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13036-019-0212-1","article-title":"Evaluation of human primary intestinal monolayers for drug metabolizing capabilities","volume":"13","author":"Speer","year":"2019","journal-title":"J Biol Eng"},{"issue":"8","key":"10.1016\/j.dmd.2025.100188_bib55","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/2050640617722903","article-title":"Human intestinal epithelium in a dish: current models for research into gastrointestinal pathophysiology","volume":"5","author":"Noben","year":"2017","journal-title":"United European Gastroenterol J"},{"issue":"11","key":"10.1016\/j.dmd.2025.100188_bib56","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3390\/pharmaceutics15112523","article-title":"Caco-2 cell line standardization with pharmaceutical requirements and in vitro model suitability for permeability assays","volume":"15","author":"Kus","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jnci\/59.1.221","article-title":"One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice","volume":"59","author":"Fogh","year":"1977","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib58","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1472-8206.2007.00550.x","article-title":"Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR","volume":"21","author":"Maubon","year":"2007","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100188_bib59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2021.05.028","article-title":"In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: a systematic review","volume":"335","author":"Fedi","year":"2021","journal-title":"J Control Release"},{"issue":"17","key":"10.1016\/j.dmd.2025.100188_bib60","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3390\/ijms23179861","article-title":"Establishment and characterization of novel human intestinal in vitro models for absorption and first-pass metabolism studies","volume":"23","author":"Przybylla","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.dmd.2025.100188_bib61","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3390\/cells12192371","article-title":"Novel in vitro models for cell differentiation and drug transport studies of the human intestine","volume":"12","author":"Przybylla","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91160-z","article-title":"Generation of tetracycline-controllable CYP3A4-expressing Caco-2 cells by the piggyBac transposon system","volume":"11","author":"Ichikawa","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib63","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s43441-023-00599-x","article-title":"Detection, monitoring, and mitigation of drug-induced nephrotoxicity: a pragmatic approach","volume":"58","author":"Antognini","year":"2024","journal-title":"Ther Innov Regul Sci"},{"issue":"4","key":"10.1016\/j.dmd.2025.100188_bib64","article-title":"Drug-induced kidney injury: challenges and opportunities","volume":"13","author":"Connor","year":"2024","journal-title":"Toxicol Res (Camb)"},{"issue":"5","key":"10.1016\/j.dmd.2025.100188_bib65","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.1980.181","article-title":"Metabolism of drugs by the kidney","volume":"18","author":"Anders","year":"1980","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.dmd.2025.100188_bib66","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3390\/bios12090718","article-title":"Functional evaluation and nephrotoxicity assessment of human renal proximal tubule cells on a chip","volume":"12","author":"Jing","year":"2022","journal-title":"Biosensors (Basel)"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib67","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ad9407","article-title":"Narrative review of proximal tubular epithelial cell in-vitro co-culture models","volume":"17","author":"Varda","year":"2024","journal-title":"Biofabrication"},{"key":"10.1016\/j.dmd.2025.100188_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152535","article-title":"Freshly isolated primary human proximal tubule cells as an in vitro model for the detection of renal tubular toxicity","volume":"442","author":"Bajaj","year":"2020","journal-title":"Toxicology"},{"issue":"11","key":"10.1016\/j.dmd.2025.100188_bib69","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1124\/dmd.118.082958","article-title":"Emerging kidney models to investigate metabolism, transport, and toxicity of drugs and xenobiotics","volume":"46","author":"Bajaj","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib70","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41581-018-0003-9","article-title":"Advances in predictive in vitro models of drug-induced nephrotoxicity","volume":"14","author":"Soo","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ki.1994.6","article-title":"HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney","volume":"45","author":"Ryan","year":"1994","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.dmd.2025.100188_bib72","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/1091581820942534","article-title":"In vitro to in vivo concordance of toxicity using the human proximal tubule cell line HK-2","volume":"39","author":"Mossoba","year":"2020","journal-title":"Int J Toxicol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.148","article-title":"Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells","volume":"3","author":"Huang","year":"2015","journal-title":"Pharmacol Res Perspect"},{"issue":"10","key":"10.1016\/j.dmd.2025.100188_bib74","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/00498254.2016.1236299","article-title":"Gene expression study of phase I and II metabolizing enzymes in RPTEC\/TERT1 cell line: application in in vitro nephrotoxicity prediction","volume":"47","author":"Shah","year":"2017","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.dmd.2025.100188_bib75","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/bcp.12086","article-title":"Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)","volume":"76","author":"Knights","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42785-9","article-title":"Micropatterned primary hepatocyte co-culture (HEPATOPAC) for fatty liver disease modeling and drug screening","volume":"13","author":"Cottier","year":"2023","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib77","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1021\/bm401926k","article-title":"Hepatocyte cocultures with endothelial cells and fibroblasts on micropatterned fibrous mats to promote liver-specific functions and capillary formation capabilities","volume":"15","author":"Liu","year":"2014","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12938-024-01226-y","article-title":"Construction of in vitro liver-on-a-chip models and application progress","volume":"23","author":"Liu","year":"2024","journal-title":"Biomed Eng Online"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib79","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00204-024-03943-8","article-title":"A new human autologous hepatocyte\/macrophage co-culture system that mimics drug-induced liver injury-like inflammation","volume":"99","author":"Zimmermann","year":"2025","journal-title":"Arch Toxicol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib80","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0022-3549(15)00192-6","article-title":"Co-culture of hepatocytes and Kupffer cells as an in vitro model of inflammation and drug-induced hepatotoxicity","volume":"105","author":"Rose","year":"2016","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib81","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12935-023-02853-6","article-title":"In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer","volume":"23","author":"Ge","year":"2023","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib82","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1038\/s41598-021-84861-y","article-title":"Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system","volume":"11","author":"Shinohara","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmd.2025.100188_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109959","article-title":"Physiological oxygen and co-culture with human fibroblasts facilitate in vivo-like properties in human renal proximal tubular epithelial cells","volume":"361","author":"Piossek","year":"2022","journal-title":"Chem Biol Interact"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib84","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/s41467-020-15337-2","article-title":"Stem cell-derived polarized hepatocytes","volume":"11","author":"Dao Thi","year":"2020","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.dmd.2025.100188_bib85","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1172\/JCI138645","article-title":"Current and potential future applications of human stem cell models in drug development","volume":"130","author":"Donowitz","year":"2020","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.dmd.2025.100188_bib86","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2174\/1389201021666200422090952","article-title":"Molecular profiling of human induced pluripotent stem cell-derived cells and their application for drug safety study","volume":"21","author":"Matsui","year":"2020","journal-title":"Curr Pharm Biotechnol"},{"issue":"9","key":"10.1016\/j.dmd.2025.100188_bib87","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00204-016-1756-1","article-title":"Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening","volume":"90","author":"G\u00f3mez-Lech\u00f3n","year":"2016","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425255.2015.981523","article-title":"Human induced pluripotent stem cell-derived hepatocytes for toxicology testing","volume":"11","author":"Mann","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/srep38694","article-title":"Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: a novel in vitro cholestatic model","volume":"6","author":"Ni","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib90","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.stemcr.2020.12.017","article-title":"Generation of human-induced pluripotent stem cell-derived functional enterocyte-like cells for pharmacokinetic studies","volume":"16","author":"Yoshida","year":"2021","journal-title":"Stem Cell Rep"},{"issue":"4","key":"10.1016\/j.dmd.2025.100188_bib91","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.dmpk.2020.04.334","article-title":"Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells","volume":"35","author":"Kabeya","year":"2020","journal-title":"Drug Metab Pharmacokinet"},{"issue":"9","key":"10.1016\/j.dmd.2025.100188_bib92","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.xphs.2023.05.013","article-title":"Evaluation of function and features of human induced pluripotent stem cell-derived small intestinal epithelial cells for analyzing peptide drug intestinal absorption profiles","volume":"112","author":"Itagaki","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.dmd.2025.100188_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149356","article-title":"Utility of human induced pluripotent stem cell-derived small intestinal epithelial cells for pharmacokinetic, toxicological, and immunological studies","volume":"692","author":"Imakura","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103597","article-title":"A gut response: application of human enteroid monolayers to probe the mechanism of the goldenseal-mediated inhibition of metformin intestinal absorption","volume":"392","author":"Arian","year":"2025","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"10.1016\/j.dmd.2025.100188_bib95","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/bios14090435","article-title":"Advanced liver-on-a-chip model for evaluating drug metabolism and hepatotoxicity","volume":"14","author":"Frojdenfal","year":"2024","journal-title":"Biosensors (Basel)"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib96","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1039\/D1LC01161H","article-title":"Exploration and application of a liver-on-a-chip device in combination with modelling and simulation for quantitative drug metabolism studies","volume":"22","author":"Docci","year":"2022","journal-title":"Lab Chip"},{"issue":"14","key":"10.1016\/j.dmd.2025.100188_bib97","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1039\/D5LC00221D","article-title":"LEADS\u2014a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing","volume":"25","author":"Balachander","year":"2025","journal-title":"Lab Chip"},{"issue":"7","key":"10.1016\/j.dmd.2025.100188_bib98","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1021\/acsbiomaterials.3c00346","article-title":"Development of an induced pluripotent stem cell-based liver-on-a-chip assessed with an Alzheimer\u2019s disease drug","volume":"9","author":"Fanizza","year":"2023","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib99","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.124.001497","article-title":"Utilization of a human Liver Tissue Chip for drug-metabolizing enzyme induction studies of perpetrator and victim drugs","volume":"53","author":"Ohri","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib100","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/adde86","article-title":"A hepatic zonation chip with an oxygen concentration gradient embracing the spatial distribution of metabolic function","volume":"17","author":"Kim","year":"2025","journal-title":"Biofabrication"},{"issue":"517","key":"10.1016\/j.dmd.2025.100188_bib101","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax5516","article-title":"Reproducing human and cross-species drug toxicities using a Liver-Chip","volume":"11","author":"Jang","year":"2019","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.dmd.2025.100188_bib102","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jhep.2023.01.019","article-title":"A human liver organoid screening platform for DILI risk prediction","volume":"78","author":"Zhang","year":"2023","journal-title":"J Hepatol"},{"issue":"18","key":"10.1016\/j.dmd.2025.100188_bib103","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1039\/D4AN00602J","article-title":"A pumpless liver-on-a-chip for drug hepatotoxicity analysis","volume":"149","author":"Jiao","year":"2024","journal-title":"Analyst"},{"key":"10.1016\/j.dmd.2025.100188_bib104","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.actbio.2024.09.012","article-title":"Emerging microfluidic gut-on-a-chip systems for drug development","volume":"188","author":"Wang","year":"2024","journal-title":"Acta Biomater"},{"key":"10.1016\/j.dmd.2025.100188_bib105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50135","article-title":"Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model","volume":"9","author":"Kasendra","year":"2020","journal-title":"Elife"},{"issue":"12","key":"10.1016\/j.dmd.2025.100188_bib106","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/aor.13163","article-title":"A biomimetic human gut-on-a-chip for modeling drug metabolism in Intestine","volume":"42","author":"Guo","year":"2018","journal-title":"Artif Organs"},{"issue":"9","key":"10.1016\/j.dmd.2025.100188_bib107","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1039\/c3ib40049b","article-title":"Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment","volume":"5","author":"Jang","year":"2013","journal-title":"Integr Biol (Camb)"},{"issue":"4","key":"10.1016\/j.dmd.2025.100188_bib108","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.xphs.2021.01.028","article-title":"Implementation of a human renal proximal tubule on a chip for nephrotoxicity and drug interaction studies","volume":"110","author":"Vormann","year":"2021","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.dmd.2025.100188_bib109","article-title":"Isolation of primary human proximal tubule epithelial cells and their use in creating a microphysiological model of the renal proximal tubule","volume":"219","author":"Chalker","year":"2025","journal-title":"J Vis Exp"},{"key":"10.1016\/j.dmd.2025.100188_bib110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fbioe.2020.00163","article-title":"Intestine-liver axis on-chip reveals the intestinal protective role on hepatic damage by emulating ethanol first-pass metabolism","volume":"8","author":"De Gregorio","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib111","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s42003-023-04710-8","article-title":"Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease","volume":"6","author":"Yang","year":"2023","journal-title":"Commun Biol"},{"issue":"20","key":"10.1016\/j.dmd.2025.100188_bib112","article-title":"An organ-on-chip platform for simulating drug metabolism along the gut-liver axis","volume":"13","author":"Lucchetti","year":"2024","journal-title":"Adv Healthc Mater"},{"issue":"7","key":"10.1016\/j.dmd.2025.100188_bib113","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1021\/acsbiomaterials.4c00605","article-title":"Perfluoropolyether-based gut-liver-on-a-chip for the evaluation of first-pass metabolism and oral bioavailability of drugs","volume":"10","author":"Wang","year":"2024","journal-title":"ACS Biomater Sci Eng"},{"issue":"12","key":"10.1016\/j.dmd.2025.100188_bib114","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1039\/D4LC00902A","article-title":"Microfluidic organoid-slice-on-a-chip system for studying anti-cholangiocarcinoma drug efficacy and hepatorenal toxicity","volume":"25","author":"Liu","year":"2025","journal-title":"Lab Chip"},{"key":"10.1016\/j.dmd.2025.100188_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1528748","article-title":"Digital twin-enhanced three-organ microphysiological system for studying drug pharmacokinetics in pregnant women","volume":"16","author":"Graf","year":"2025","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10928-024-09955-2","article-title":"Multiorgan-on-a-chip for cancer drug pharmacokinetics-pharmacodynamics (PK-PD) modeling and simulations","volume":"52","author":"Mohammed","year":"2024","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib117","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10529-020-03043-4","article-title":"Evaluation of hepatic drug-metabolism for glioblastoma using liver-brain chip","volume":"43","author":"Li","year":"2021","journal-title":"Biotechnol Lett"},{"issue":"17","key":"10.1016\/j.dmd.2025.100188_bib118","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94954","article-title":"Human hepatic organoids for the analysis of human genetic diseases","volume":"2","author":"Guan","year":"2017","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.dmd.2025.100188_bib119","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/toxics12050371","article-title":"Validating well-functioning hepatic organoids for toxicity evaluation","volume":"12","author":"Choi","year":"2024","journal-title":"Toxics"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib120","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/s41467-021-23575-1","article-title":"Generation of functional liver organoids on combining hepatocytes and cholangiocytes with hepatobiliary connections ex vivo","volume":"12","author":"Tanimizu","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib121","article-title":"Hepatotoxicity evaluation method through multiple-factor analysis using human pluripotent stem cell derived hepatic organoids","volume":"15","author":"Shin","year":"2025","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib122","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s43188-024-00275-8","article-title":"Current hPSC-derived liver organoids for toxicity testing: cytochrome P450 enzymes and drug metabolism","volume":"41","author":"Kim","year":"2025","journal-title":"Toxicol Res"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib123","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/acsptsci.4c00612","article-title":"Amino acid hepatotoxicity biomarkers in human hepatic organoids: promising standardization of drug toxicity evaluation","volume":"8","author":"Noh","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib124","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13287-025-04139-2","article-title":"Advances in liver organoids: replicating hepatic complexity for toxicity assessment and disease modeling","volume":"16","author":"Shao","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.dmd.2025.100188_bib125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/a-1934-5588","article-title":"Three-dimensional organoids as a model to study nonalcoholic fatty liver disease","volume":"42","author":"Park","year":"2022","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib126","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13287-025-04264-y","article-title":"From gut to liver: organoids as platforms for next-generation toxicology assessment vehicles for xenobiotics","volume":"16","author":"Alnasser","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib127","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.3390\/ijms24032856","article-title":"Kidney drug transporters in pharmacotherapy","volume":"24","author":"\u0141apczuk-Roma\u0144ska","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dmd.2025.100188_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1138504","article-title":"ATP\/ADP biosensor organoids for drug nephrotoxicity assessment","volume":"11","author":"Susa","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.dmd.2025.100188_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2022.102763","article-title":"In vitro differentiation of pluripotent stem cells into hepatocyte like cells\u2014basic principles and current progress","volume":"61","author":"Graffmann","year":"2022","journal-title":"Stem Cell Res"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2014.10.016","article-title":"Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes","volume":"62","author":"Baxter","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dmd.2025.100188_bib131","article-title":"A novel system for evaluating the inhibition effect of drugs on cytochrome P450 enzymes in vitro based on human-induced hepatocytes (hiHeps)","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib132","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.stem.2014.01.008","article-title":"Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming","volume":"14","author":"Du","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.dmd.2025.100188_bib133","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s12015-025-10893-w","article-title":"Engineering the future of regenerative medicines in gut health with stem cell-derived intestinal organoids","volume":"21","author":"Kumar","year":"2025","journal-title":"Stem Cell Rev Rep"},{"issue":"8","key":"10.1016\/j.dmd.2025.100188_bib134","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/stmcls\/sxad042","article-title":"The effect of vitamin D3 and valproic acid on the maturation of human-induced pluripotent stem cell-derived enterocyte-like cells","volume":"41","author":"Leo","year":"2023","journal-title":"Stem Cells"},{"key":"10.1016\/j.dmd.2025.100188_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.765980","article-title":"Induction and maturation of hepatocyte-like cells in vitro: focus on technological advances and challenges","volume":"9","author":"Xie","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.dmd.2025.100188_bib136","first-page":"50","article-title":"Therapeutic strategies of three-dimensional stem cell spheroids and organoids for tissue repair and regeneration","volume":"19","author":"Kim","year":"2023","journal-title":"Bioact Mater"},{"issue":"23","key":"10.1016\/j.dmd.2025.100188_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312690","article-title":"The ECM: to scaffold, or not to scaffold, that is the question","volume":"22","author":"Valdoz","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.dmd.2025.100188_bib138","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512528","article-title":"Application of human brain organoids-opportunities and challenges in modeling human brain development and neurodevelopmental diseases","volume":"24","author":"Kim","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.dmd.2025.100188_bib139","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41582-022-00723-9","article-title":"Human cerebral organoids\u2014a new tool for clinical neurology research","volume":"18","author":"Eichm\u00fcller","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00441-021-03565-x","article-title":"Kidney organoids: current knowledge and future directions","volume":"387","author":"Khoshdel-Rad","year":"2022","journal-title":"Cell Tissue Res"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib141","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","article-title":"In vitro models for the study of liver biology and diseases: advances and limitations","volume":"15","author":"Kaur","year":"2023","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100188_bib142","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41551-020-0539-4","article-title":"Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity","volume":"4","author":"Richards","year":"2020","journal-title":"Nat Biomed Eng"},{"issue":"31","key":"10.1016\/j.dmd.2025.100188_bib143","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.2174\/0929867331666230727104911","article-title":"Cardiac organoids: a 3D technology for disease modeling and drug screening","volume":"31","author":"Zhu","year":"2024","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib144","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/HEP.0000000000000343","article-title":"Human liver organoids: from generation to applications","volume":"79","author":"Afonso","year":"2024","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib145","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3390\/nu13030886","article-title":"The interplay between the gut microbiome and the immune system in the context of infectious diseases throughout life and the role of nutrition in optimizing treatment strategies","volume":"13","author":"Wiertsema","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib146","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0168-3659(95)00147-6","article-title":"Intestinal drug metabolism and antitransport processes: a potential paradigm shift in oral drug delivery","volume":"39","author":"Benet","year":"1996","journal-title":"J Control Rel"},{"issue":"8","key":"10.1016\/j.dmd.2025.100188_bib147","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.hlife.2025.01.001","article-title":"The crucial function of gut microbiota on gut\u2013liver repair","volume":"3","author":"Wang","year":"2025","journal-title":"hLife"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut microbiota functions: metabolism of nutrients and other food components","volume":"57","author":"Rowland","year":"2018","journal-title":"Eur J Nutr"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib149","doi-asserted-by":"crossref","first-page":"F1307","DOI":"10.1152\/ajprenal.00046.2009","article-title":"Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity","volume":"296","author":"Xia","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"10.1016\/j.dmd.2025.100188_bib150","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.apsb.2016.07.013","article-title":"Renal drug transporters and their significance in drug-drug interactions","volume":"6","author":"Yin","year":"2016","journal-title":"Acta Pharm Sin B"},{"issue":"11","key":"10.1016\/j.dmd.2025.100188_bib151","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.3390\/ijms22116109","article-title":"The mechanism of drug nephrotoxicity and the methods for preventing kidney damage","volume":"22","author":"Kwiatkowska","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib152","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s42826-022-00128-1","article-title":"Role of animal models in biomedical research: a review","volume":"38","author":"Mukherjee","year":"2022","journal-title":"Lab Anim Res"},{"issue":"4","key":"10.1016\/j.dmd.2025.100188_bib153","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13734","article-title":"Drug metabolism in animal models and humans: translational aspects and chances for individual therapy","volume":"233","author":"Indorf","year":"2021","journal-title":"Acta Physiol (Oxf)"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib154","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.apsb.2012.10.004","article-title":"Preclinical experimental models of drug metabolism and disposition in drug discovery and development","volume":"2","author":"Zhang","year":"2012","journal-title":"Acta Pharm Sin B"},{"issue":"7","key":"10.1016\/j.dmd.2025.100188_bib155","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1139\/cjpp-2015-0459","article-title":"Toxicity testing and drug screening using iPSC-derived hepatocytes, cardiomyocytes, and neural cells","volume":"94","author":"Cs\u00f6b\u00f6nyeiov\u00e1","year":"2016","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib156","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tips.2020.11.009","article-title":"Organ-on-a-chip: a new paradigm for drug development","volume":"42","author":"Ma","year":"2021","journal-title":"Trends Pharmacol Sci"},{"issue":"7517","key":"10.1016\/j.dmd.2025.100188_bib157","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.331.7517.633","article-title":"Chocolate poisoning","volume":"331","author":"Finlay","year":"2005","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.dmd.2025.100188_bib158","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0041-008X(80)90360-9","article-title":"Effects of short-term and long-term theobromine administration to male dogs","volume":"53","author":"Gans","year":"1980","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.dmd.2025.100188_bib159","first-page":"266","article-title":"Modeling physiological events in 2D vs. 3D cell culture","volume":"32","author":"Duval","year":"2017","journal-title":"Physiology (Bethesda)"},{"issue":"7","key":"10.1016\/j.dmd.2025.100188_bib160","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/2472555220915827","article-title":"Comparison of cell and organoid-level analysis of patient-derived 3D organoids to evaluate tumor cell growth dynamics and drug response","volume":"25","author":"Kim","year":"2020","journal-title":"SLAS Discov"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib161","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13619-025-00226-0","article-title":"Standard: human liver-on-a-chip","volume":"14","author":"Liu","year":"2025","journal-title":"Cell Regen"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188527","article-title":"Recent advances in organoid development and applications in disease modeling","volume":"1875","author":"Rauth","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib163","doi-asserted-by":"crossref","DOI":"10.59717\/j.xinn-life.2024.100115","article-title":"When artificial intelligence (AI) meets organoids and organs-on-chips (OoCs): Game-changer for drug discovery and development?","volume":"3","author":"Zhou","year":"2025","journal-title":"Innov Life"},{"issue":"2","key":"10.1016\/j.dmd.2025.100188_bib164","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5653\/cerm.2024.06954","article-title":"State-of-the-art in high throughput organ-on-chip for biotechnology and pharmaceuticals","volume":"52","author":"Song","year":"2025","journal-title":"Clin Exp Reprod Med"},{"issue":"5","key":"10.1016\/j.dmd.2025.100188_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103515","article-title":"Pharma's Bio-AI revolution","volume":"28","author":"Bentwich","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.dmd.2025.100188_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2024.116632","article-title":"Integrating machine learning and biosensors in microfluidic devices: a review","volume":"263","author":"Antonelli","year":"2024","journal-title":"Biosens Bioelectron"},{"issue":"5","key":"10.1016\/j.dmd.2025.100188_bib167","first-page":"369","article-title":"Give them vasculature and immune cells: how to fill the gap of organoids","volume":"212","author":"Yip","year":"2023","journal-title":"Cells Tissues Organs"},{"issue":"1","key":"10.1016\/j.dmd.2025.100188_bib168","article-title":"Advances in 3D bioprinting","volume":"1","author":"Fang","year":"2022","journal-title":"Chin J Mech Eng Addit Manuf Front"},{"issue":"6","key":"10.1016\/j.dmd.2025.100188_bib169","article-title":"Bioengineering methods for vascularizing organoids","volume":"4","author":"Nwokoye","year":"2024","journal-title":"Cell Rep Methods"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625094978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625094978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:00:49Z","timestamp":1773874849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625094978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":169,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0090955625094978"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100188","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel emerging cell and organoid systems for the study of drug metabolism and toxicity in humans","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100188"}}